| |
| |
|
| Insider
Information: |
Sing George L |
| Relationship: |
Director |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
27,472 |
|
|
Indirect Shares
|
2,150 |
|
|
| Direct
Value |
$27,060,469 |
|
|
|
Indirect Value
|
$2,117,793 |
|
|
| Total
Shares |
29,622 |
|
|
| Total
Value |
$29,178,262 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
34
|
|
Stock
price went up :
|
0
|
17
|
| Stock
price went down : |
0
|
17
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 3.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2024-05-03 |
27,472 |
2024-05-03 |
2,150 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2012-05-30 |
4 |
S |
$134.00 |
$670,000 |
D/D |
(5,000) |
142,772 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2012-05-31 |
4 |
S |
$134.74 |
$674,397 |
D/D |
(5,000) |
137,772 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2012-07-26 |
4 |
S |
$135.00 |
$675,000 |
D/D |
(5,000) |
137,772 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2012-08-22 |
4 |
S |
$139.00 |
$695,000 |
D/D |
(5,000) |
137,772 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2012-08-23 |
4 |
S |
$142.00 |
$710,000 |
D/D |
(5,000) |
137,772 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2012-11-13 |
4 |
S |
$148.00 |
$740,000 |
D/D |
(5,000) |
132,772 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2012-11-16 |
4 |
S |
$152.00 |
$760,000 |
D/D |
(5,000) |
127,772 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2012-11-29 |
4 |
S |
$185.00 |
$925,000 |
D/D |
(5,000) |
122,772 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2013-05-10 |
4 |
S |
$270.00 |
$1,350,000 |
D/D |
(5,000) |
112,772 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2013-11-26 |
4 |
S |
$295.00 |
$2,950,000 |
D/D |
(10,000) |
112,772 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2014-02-14 |
4 |
S |
$324.00 |
$4,860,000 |
D/D |
(15,000) |
112,772 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2014-02-21 |
4 |
S |
$338.00 |
$5,085,000 |
D/D |
(15,000) |
112,772 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2015-02-20 |
4 |
S |
$423.12 |
$6,346,800 |
D/D |
(15,000) |
112,772 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2015-05-27 |
4 |
S |
$515.00 |
$2,575,000 |
D/D |
(5,000) |
112,772 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2015-11-18 |
4 |
S |
$580.00 |
$290,000 |
I/I |
(500) |
4,500 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2015-11-18 |
4 |
S |
$580.00 |
$1,740,000 |
D/D |
(3,000) |
112,772 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2018-05-09 |
4 |
S |
$285.29 |
$1,997,030 |
D/D |
(7,000) |
127,772 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2018-05-10 |
4 |
S |
$285.00 |
$3,726,000 |
D/D |
(13,000) |
114,772 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-02-26 |
4 |
S |
$450.00 |
$1,086,800 |
I/I |
(2,400) |
9,000 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-02-26 |
4 |
S |
$460.00 |
$1,150,000 |
D/D |
(2,500) |
115,415 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-05-11 |
4 |
S |
$575.00 |
$488,750 |
I/I |
(850) |
8,700 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-05-13 |
4 |
S |
$580.00 |
$2,900,000 |
D/D |
(5,000) |
115,415 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-05-28 |
4 |
S |
$578.00 |
$579,000 |
I/I |
(1,000) |
8,200 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-05-29 |
4 |
S |
$595.00 |
$596,510 |
I/I |
(1,000) |
7,700 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-08-20 |
4 |
S |
$615.48 |
$12,955,042 |
D/D |
(21,000) |
104,415 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
